Protective role of normothermic, hyperthermic and estrogen preconditioning and pretreatment on tumour necrosis factor-alpha-induced damage

Experimental and Clinical Cardiology

Volumn 16, Issue 2, 2011, Pages

  Juggi, Jasbir S ^a   Hoteit, Lamia J ^a   Babiker, Fawzi A ^a   Joseph, Shaji ^a   Mustafa, Abu Salim ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Estrogen; Ischemia and reperfusion; Preconditioning; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; ESTROGEN PRECONDITIONING; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPERTHERMIC ISCHEMIC PRECONDITIONING; ISCHEMIC PRECONDITIONING; ISOLATED HEART; MALE; NONHUMAN; NORMOTHERMIC ISCHEMIC PRECONDITIONING; RAT; REPERFUSION INJURY;

EID: 79957879598     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004;61:461-70. (Pubitemid 38210152)
2. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36. (Pubitemid 17174962)
3. Li Y, Kloner RA. The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts. Circulation 1993;87:1642-8.
4. Gysembergh A, Margonari H, Loufoua J, et al. Stretch-induced protection shares a common mechanism with ischemic preconditioning in rabbit heart. Am J Physiol 1998;274:H955-64.
5. Huang CH, Wang JS, Chiang SC, Wang YY, Lai ST, Weng ZC. Brief pressure overload of the left ventricle preconditions rabbit myocardium against infarction. Ann Thorac Surg 2004;78:628-33.
6. Sovershaev MA, Egorina EM, Andreasen TV, Jonassen AK, Ytrehus K. Preconditioning by 17beta-estradiol in isolated rat heart depends on PI3-K/PKB pathway, PKC, and ROS. Am J Physiol Heart Circ Physiol 2006;291:H1554-62.
7. Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M. Ventricular overdrive pacing-induced anti-ischemic effect: A conscious rabbit model of preconditioning. Am J Physiol 1994;266:H2033-41.
8. Vanagt WY, Cornelussen RN, Poulina QP, et al. Pacing-induced dys-synchrony preconditions rabbit myocardium against ischemia/ reperfusion injury. Circulation 2006;114:I264-9.
9. Vegh A, Szekeres L, Parratt JR. Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res 1991;25:1051-3.
10. Xu Y, Arenas IA, Armstrong SJ, Plahta WC, Xu H, Davidge ST. Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha. Cardiovasc Res 2006;69:836-44. (Pubitemid 43227982)
11. Meldrum DR, Dinarello CA, Shames BD, et al. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning. Circulation 1998;98:II214-8; discussion II218-9.
12. Oral H, Kapadia S, Nakano M, et al. Tumor necrosis factor-alpha and the failing human heart. Clin Cardiol 1995;18:IV20-7.
13. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-3. (Pubitemid 27056193)
14. Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, Sack MN. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol 2002;34:509-18.
15. Tanno M, Gorog DA, Bellahcene M, Cao X, Quinlan RA, Marber MS. Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation. J Mol Cell Cardiol 2003;35:1523-7. (Pubitemid 37491195)
16. Babiker FA, Lips DJ, Delvaux E, et al. Oestrogen modulates cardiac ischaemic remodelling through oestrogen receptor-specific mechanisms. Acta Physiol (Oxf) 2007;189:23-31. (Pubitemid 46092427)
17. van Eickels M, Patten RD, Aronovitz MJ, et al. 17-beta-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. J Am Coll Cardiol 2003;41:2084-92. (Pubitemid 36677136)
18. Jovanovic S, Jovanovic A, Shen WK, Terzic A. Low concentrations of 17beta-estradiol protect single cardiac cells against metabolic stress-induced Ca2+ loading. J Am Coll Cardiol 2000;36:948-52.
19. Zhai P, Eurell TE, Cotthaus R, Jeffery EH, Bahr JM, Gross DR. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol 2000;279:H2766-75.
20. Das B, Sarkar C. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart. J Cardiovasc Pharmacol 2006;47:277-86. (Pubitemid 44389140)
21. McNulty PH, Jagasia D, Whiting JM, Caulin-Glaser T. Effect of 6-wk estrogen withdrawal or replacement on myocardial ischemic tolerance in rats. Am J Physiol Heart Circ Physiol 2000;278:H1030-4.
22. Ghadhanfar EA, Juggi JS. Effect of preconditioning temperature on cardioprotection during global ischemia-reperfusion in the rat heart. Exp Clin Cardiol 2007;12:11-6. (Pubitemid 46566810)
23. Yang J, Jiang H, Yang J, Ding JW, Chen LH, Li S, Zhang XD. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway. Mol Cell Biochem 2009;330:39-46.
24. Lecour S, Suleman N, Deuchar GA, et al. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation 2005;112:3911-8. (Pubitemid 43739489)
25. Belosjorow S, Schulz R, Dorge H, Schade FU, Heusch G. Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits. Am J Physiol 1999;277:H2470-5.
26. Deuchar GA, Opie LH, Lecour S. TNF alpha is required to confer protection in an in vivo model of classical ischaemic preconditioning. Life Sci 2007;80:1686-91. (Pubitemid 46463923)
27. Lacerda L, Smith RM, Opie L, Lecour S. TNF alpha-induced cytoprotection requires the production of free radicals within mitochondria in C2C12 myotubes. Life Sci 2006;79:2194-201. (Pubitemid 44649203)
28. Serhan CN. Novel omega-3-derived local mediators in anti-inflammation and resolution. Pharmacol Ther 2005;105:7-21.
29. Serhan CN, Jain A, Marleau S, et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003;171:6856-65. (Pubitemid 37532121)
30. Dorge H, Schulz R, Belosjorow S, et al. Coronary microembolization: The role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol 2002;34:51-62. (Pubitemid 34146395)
31. Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, Heusch G. Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: Progressive contractile dysfunction versus delayed protection against infarction. Circ Res 2007;100:140-6. (Pubitemid 46066782)
32. Barnes PJ, Karin M. Nuclear factor-kappaB. A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71. (Pubitemid 27163860)
33. Kaloustian S, Bah TM, Rondeau I, et al. Tumor necrosis factor-alpha participates in apoptosis in the limbic system after myocardial infarction. Apoptosis 2009;14:1308-16.
34. Fernandez-Velasco M, Ruiz-Hurtado G, Hurtado O, Moro MA, Delgado C. TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. Am J Physiol Heart Circ Physiol 2007;293:H238-45.
35. Rainbow RD, Lodwick D, Hudman D, Davies NW, Norman RI, Standen NB. SUR2A C-terminal fragments reduce KATP currents and ischaemic tolerance of rat cardiac myocytes. J Physiol 2004;557:785-94. (Pubitemid 38961616)
36. Yang XM, Philipp S, Downey JM, Cohen MV. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 2005;100:57-63. (Pubitemid 40069107)
37. Zatta AJ, Kin H, Lee G, et al. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res 2006;70:315-24.
38. Schulz R, Heusch G. Tumor necrosis factor-alpha and its receptors 1 and 2. Yin and Yang in myocardial infarction? Circulation 2009;119:1355-7.
39. Jiang SH, Liu CF, Zhang XL, et al. Renal protection by delayed ischaemic preconditioning is associated with inhibition of the inflammatory response and NF-kappaB activation. Cell Biochem Funct 2007;25:335-43.
40. Yao Z, Gross GJ. The ATP-dependent potassium channel: An endogenous cardioprotective mechanism. J Cardiovasc Pharmacol 1994;24:S28-34.
41. Sumi D, Hayashi T, Jayachandran M, Iguchi A. Estrogen prevents destabilization of endothelial nitric oxide synthase mRNA induced by tumor necrosis factor alpha through estrogen receptor mediated system. Life Sci 2001;69:1651-60. (Pubitemid 32800644)
42. Dubey RK, Jackson EK. Cardiovascular protective effects of 17beta-estradiol metabolites. J Appl Physiol 2001;91:1868-83. (Pubitemid 32900383)
43. Mugge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro. Cardiovasc Res 1993;27:1939-42. (Pubitemid 23357336)
44. Yang S, Bae L, Zhang L. Estrogen increases eNOS and NOx release in human coronary artery endothelium. J Cardiovasc Pharmacol 2000;36:242-7. (Pubitemid 30659846)
45. Jiang CW, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br J Pharmacol 1991;104:1033-7.
46. + channels. Circ Res 1996;79:1024-30.
47. + channel openers in guinea-pig ventricular cells. Br J Pharmacol 1997;120:1568-74.
48. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-7. (Pubitemid 36736635)
49. Honma Y, Tani M, Takayama M, Yamamura K, Hasegawa H. Aging abolishes the cardioprotective effect of combination heat shock and hypoxic preconditioning in reperfused rat hearts. Basic Res Cardiol 2002;97:489-95. (Pubitemid 35373477)
50. Honma Y, Tani M, Yamamura K, Takayama M, Hasegawa H. Preconditioning with heat shock further improved functional recovery in young adult but not in middle-aged rat hearts. Exp Gerontol 2003;38:299-306. (Pubitemid 36170325)
51. Featherstone RL, Chambers DJ. Long-term hypothermic lung preservation: Does adenosine A1 receptor antagonism have a role in ischemic preconditioning protection? Interact Cardiovasc Thorac Surg 2004;3:182-7.